Cargando…

Cognition and chronic hypoxia in pulmonary diseases

Lung disease with chronic hypoxia has been associated with cognitive impairment of the subcortical type. OBJECTIVES: To review the cognitive effects of chronic hypoxia in patients with lung disease and its pathophysiology in brain metabolism. METHODS: A literature search of Pubmed data was performed...

Descripción completa

Detalles Bibliográficos
Autores principales: Areza-Fegyveres, Renata, Kairalla, Ronaldo A., Carvalho, Carlos R.R., Nitrini, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação de Neurologia Cognitiva e do Comportamento 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619525/
https://www.ncbi.nlm.nih.gov/pubmed/29213655
http://dx.doi.org/10.1590/S1980-57642010DN40100003
Descripción
Sumario:Lung disease with chronic hypoxia has been associated with cognitive impairment of the subcortical type. OBJECTIVES: To review the cognitive effects of chronic hypoxia in patients with lung disease and its pathophysiology in brain metabolism. METHODS: A literature search of Pubmed data was performed. The words and expressions from the text subitems including “pathophysiology of brain hypoxia”, “neuropsychology and hypoxia”, “white matter injury and chronic hypoxia”, for instance, were key words in a search of reports spanning from 1957 to 2009. Original articles were included. RESULTS: According to national and international literature, patients with chronic obstructive pulmonary disease and sleep obstructive apnea syndrome perform worse on tests of attention, executive functions and mental speed. The severity of pulmonary disease correlates with degree of cognitive impairment. These findings support the diagnosis of subcortical type encephalopathy. CONCLUSION: Cognitive effects of clinical diseases are given limited importance in congresses and symposia about cognitive impairment and its etiology. Professionals that deal with patients presenting cognitive loss should be aware of the etiologies outlined above as a major cause or potential contributory factors, and of their implications for treatment adherence and quality of life.